AMPK Activation Stimulates Autophagy and Ameliorates Muscular Dystrophy in the mdx Mouse Diaphragm

Pauly, Marion, Daussin, Frederic, Burelle, Yan, Li, Tong, Godin, Richard, Fauconnier, Jeremy, Koechlin-Ramonatxo, Christelle, Hugon, Gerald, Lacampagne, Alain, Coisy-Quivy, Marjorie, Liang, Feng, Hussain, Sabah, Matecki, Stefan, Petrof, Basil J.·2012·The American Journal of Pathology
DOI 10.1016/j.ajpath.2012.04.004

Cited by (225)

Items 201–225 of 225

  1. Evaluating the PGC-1 alpha pathway and a new preclinical model to advance treatment options for dystrophinopathies
    Katrin Hollinger · 2014
  2. WITHDRAWN: Relationship between the regulation of muscle atrophy and mitochondrial turnover during chronic disuse
    Liam D. Tryon, Anna Vainshtein, Jonathan Matthew Memme, Matthew J. Crilly, David Albert Hood · 2016 · Integrative Medicine Research
  3. Determining the Contribution of Utrophin A Versus Other Components of the Slow, Oxidative Phenotype in the Beneficial Adaptations of Dystrophic Muscle Fibers Following AMPK Activation
    Hasanen Al-Rewashdy · 2014 · uO Research (University of Ottawa)
  4. A Review of Mathematical Models for Muscular Dystrophy: A Systems Biology Approach
    Amanda N. Cameron, Matthew T. Houston, Juan B. Gutiérrez · 2016 · arXiv (Cornell University)
  5. Estudo comparativo da contratilidade e das propriedades passivas do músculo diafragma do mdx, mdx/utrn+/- e C57Bl10 com diferentes idades
    Thaís Borges Lessa · 2016
  6. Análise da via autofágica no músculo distrófico
    Stephanie Fernandes · 2017 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  7. Bet on autophagy in the race against muscular dystrophies
    Giorgia Catarinella, Lucia Latella · 2018 · Muscle & Nerve
  8. Autophagy as a Pathogenetic Link and a Target for Therapy of Musculoskeletal System Diseases
    K. K. Kalugina, К. С. Сухарева, Anna I. Churkina, Anna Aleksandrovna Kostareva · 2021 · Journal of Evolutionary Biochemistry and Physiology
  9. Prox1 gene transfer combined with voluntary exercise improves dystrophic muscle fragility in Mdx mice
    Alexandra Monceau, Clément Delacroix, Mégane Lemaître, Onnik Agbulut, Denis Furling, Arnaud F. Klein, Arnaud Ferry · 2020
  10. Efeitos da terapia com diodo emissor de luz (LEDT) sobre as células musculares distróficas de camundongos mdx
    Guilherme Luiz da Rocha · 2021
  11. The Effect of 12 Weeks of Resistance Training on Serum Levels of Myonectin and FGF-21 in Inactive Middle-aged Men
    Zahra Yousefvand, Masoud Rahmati, Rahim Mirnasuri · 2024 · مجله دانشگاه علوم پزشکی اراک
  12. Targeting membrane fragility in LGMD R2 through pharmacological autophagy induction
    Noëlla Grossi, Emilie Pellier, Quentin Miagoux, Manon Benabidès, Jérôme Polentes, Céline Leteur, Céline Bruge, Xavier Nissan · 2025 · Research Square
  13. The D2.B10-Dmd/J Mouse Model of Duchenne Muscular Dystrophy Exhibits a Severe Mitochondrial Deficiency Not Observed in the C57BL/10ScSn-Dmd/J Mouse
    Jennifer A Tinklenberg, Jessica Sutton, Rebecca A. Slick, Hui Meng, Margaret Haberman, Mariah J. Prom, Margaret J. Beatka, Tatyana A. Vetter, Audrey L. Daugherty, Christina A. Pacak et al. · 2025 · American Journal Of Pathology
  14. Investigating the Potential Effectiveness of Two Therapeutic Targets, Utrophin and HSP70, in the Treatment of Duchenne Muscular Dystrophy
    Daniel Spensieri · 2014 · Spectrum Research Repository (Concordia University)
  15. Obestatin Treatment Counteracts Muscle Wasting by Reactivation of Autophagy in Duchenne Muscular Dystrophy
    Icía Santos‐Zas, Silvia Costas-Abalde, Andrea C. Lodeiro, Fátima Fernández‐Barreiro, Tania Cid-Diaz, Saúl Leal‐López, Jessica González‐Sánchez, Mar García‐Lamela, Lucía Debasa-Corral, Carlos S. Mosteiro et al. · 2026 · MedComm
  16. Étude des liens entre les acteurs de la dynamique mitochondriale et l'apoptose dans la dégénérescence musculaire dystrophinedépendante chez Caenorhabditis elegans
    Charlotte Scholtes · 2018 · theses.fr (ABES)
  17. Physiopathologie musculaire et implication des cellules satellites dans la maladie de Pompe (glycogénose de type II)
    Lydie Lagalice · 2018
  18. Recherche de nouvelles cibles thérapeutiques dans la myopathie de Duchenne basée sur des miRNAs dérégulés nouvellement identifiéss
    Mathilde Sanson · 2018
  19. Novel pathological mechanisms support new therapeutic opportunities in Duchenne Muscular Dystrophy
    Ai Vu Hong · 2021 · theses.fr (ABES)
  20. Biocompatible nanosystems for innovative applications of small therapeutic molecules
    Ilaria Andreana · 2022
  21. Lysosomal defects in Duchenne muscular dystrophy : advancing combined therapeutic approaches
    Abbass Jaber · 2024 · theses.fr (ABES)
  22. (-)-Epicatechin modulates skeletal muscle inflammatory response in a mouse model of Limb-Girdle Muscular Dystrophy 2F
    Amairani Cancino-Bello, Mauricio Hernández-Somilleda, Erick Bahena-Culhuac, Estela G. García-González, Oscar Hernández-Hernández, Magally Ramírez-Ramírez, Ramón Mauricio Coral-Vázquez, José Manuel Hernández-Hernández · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Consistent MYORG Downregulation in DMD and LGMD: Transcriptomic and Proteomic Evidence Supporting Deoxygalactonojirimycin Repurposing
    Rangaprasad Sarangarajan, Kastoori Iyengar · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  24. The AMPK signaling pathway in cell metabolism and human diseases
    Zhengkui Zhang, Yuanzhuo Gu, HongChao He, Shilei Qiao, Yifan Shao, 龙先铭, Jun Huang, Long Zhang, Fangfang Zhou · 2026 · Signal Transduction and Targeted Therapy
  25. Elucidation of Emergent Regional Mechanisms of Heart Muscle Dysfunction in the Mouse Model of Duchenne Muscular Dystrophy
    Ya‐Jian Cheng · 2014 · Open Scholarship Institutional Repository (Washington University in St. Louis)